PHYTOHEALTH CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.9 TWD | +0.51% |
|
+2.31% | -8.29% |
| Sales 2022 | 135M 4.17M 348M | Sales 2023 | 162M 5M 417M | Capitalization | 4.31B 133M 11.06B |
|---|---|---|---|---|---|
| Net income 2022 | -79M -2.43M -203M | Net income 2023 | -47M -1.45M -121M | EV / Sales 2022 | 18.2 x |
| Net cash position 2022 | 1.33B 40.93M 3.41B | Net cash position 2023 | 1.24B 38.08M 3.18B | EV / Sales 2023 | 18.9 x |
| P/E ratio 2022 |
-47.8
x | P/E ratio 2023 |
-91.5
x | Employees | 84 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.02% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.51% | ||
| 1 week | +2.31% | ||
| Current month | -3.40% | ||
| 1 month | -4.33% | ||
| 3 months | -7.44% | ||
| 6 months | -1.49% | ||
| Current year | -8.29% |
1 week
19.40
20.10
1 month
19.2020.85
Current year
19.2023.50
1 year
19.2025.25
3 years
17.0527.85
5 years
10.2541.05
10 years
10.2548.70
| Managers | Title | Age | Since |
|---|---|---|---|
I Lin Lee
CEO | Chief Executive Officer | - | 13/17/13 |
Chih Yuan Huang
DFI | Director of Finance/CFO | - | 11/21/11 |
Teng Hsu Wang
CTO | Chief Tech/Sci/R&D Officer | - | 30/21/30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ching Chung Tsai
BRD | Director/Board Member | - | 12/14/12 |
Yue Ju Lai
BRD | Director/Board Member | - | 20/02/20 |
Yi Li Lee
CHM | Chairman | 53 | 20/02/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 19.9 | +0.51% | 195 368 |
| 26/24/26 | 19.8 | 0.00% | 124,567 |
| 25/24/25 | 19.8 | -1.00% | 124,291 |
| 24/24/24 | 20 | +1.01% | 186,840 |
| 23/24/23 | 19.8 | +1.80% | 181,585 |
End-of-day quote Taiwan S.E., April 29, 2024
More quotes
PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
07/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.29% | 121M | |
| -4.06% | 86.13B | |
| +1.97% | 39.82B | |
| +56.59% | 25.23B | |
| -13.79% | 15.36B | |
| -8.82% | 11.95B | |
| -15.27% | 11.6B | |
| -41.58% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
- Stock Market
- Equities
- 4108 Stock
